These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31582062)

  • 21. Topical protection of human esophageal mucosal integrity.
    Woodland P; Batista-Lima F; Lee C; Preston SL; Dettmar P; Sifrim D
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G975-80. PubMed ID: 25907692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis.
    Zentilin P; Savarino V; Marabotto E; Murdaca G; Sulli A; Pizzorni C; Puppo F; Savarino E
    Semin Arthritis Rheum; 2018 Feb; 47(4):569-574. PubMed ID: 28870413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oesophagitis on proximal extent of gastro-oesophageal reflux.
    Emerenziani S; Cicala M; Zhang X; Ribolsi M; Caviglia R; Guarino MP; Sifrim D
    Neurogastroenterol Motil; 2007 Jun; 19(6):459-64. PubMed ID: 17564627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A baseline impedance analysis in neurologically impaired children: A potent parameter for estimating the condition of the esophageal mucosa.
    Fukahori S; Yagi M; Ishii S; Asagiri K; Saikusa N; Hashizume N; Yoshida M; Masui D; Komatsuzaki N; Higashidate N; Nakahara H; Tanaka Y
    Neurogastroenterol Motil; 2017 Jun; 29(6):. PubMed ID: 28086260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
    Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease.
    Broeders JA; Draaisma WA; Bredenoord AJ; Smout AJ; Broeders IA; Gooszen HG
    Br J Surg; 2010 Jun; 97(6):845-52. PubMed ID: 20473997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients.
    Deppe H; Mücke T; Wagenpfeil S; Kesting M; Rozej A; Bajbouj M; Sculean A
    BMC Oral Health; 2015 Jul; 15():84. PubMed ID: 26208714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of TRPV1 receptor in inflammation and impairment of esophageal mucosal integrity in a murine model of nonerosive reflux disease.
    Silva RO; Bingana RD; Sales TMAL; Moreira RLR; Costa DVS; Sales KMO; Brito GAC; Santos AA; Souza MÂN; Soares PMG; Sifrim D; Souza MHLP
    Neurogastroenterol Motil; 2018 Mar; ():e13340. PubMed ID: 29573069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Miwa H; Sasaki M; Furuta T; Koike T; Habu Y; Ito M; Fujiwara Y; Wada T; Nagahara A; Hongo M; Chiba T; Kinoshita Y;
    Aliment Pharmacol Ther; 2007 Jul; 26(1):69-77. PubMed ID: 17555423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct proteomic profiles characterise non-erosive from erosive reflux disease.
    Calabrese C; Marzano V; Urbani A; Lazzarini G; Valerii MC; Liguori G; Di Molfetta S; Rizzello F; Gionchetti P; Campieri M; Spisni E
    Aliment Pharmacol Ther; 2011 Oct; 34(8):982-93. PubMed ID: 21848794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results.
    Galmiche JP
    Drugs; 2006; 66 Suppl 1():7-13; discussion 29-33. PubMed ID: 16869343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
    Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R
    Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
    Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of adhesion of swallowed alginates to distal oesophageal mucosa: implications for topical therapy of oesophageal diseases.
    Sonmez S; Coyle C; Sifrim D; Woodland P
    Aliment Pharmacol Ther; 2020 Aug; 52(3):442-448. PubMed ID: 32548849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease.
    Emerenziani S; Ribolsi M; Sifrim D; Blondeau K; Cicala M
    Neurogastroenterol Motil; 2009 Mar; 21(3):253-8. PubMed ID: 19019016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidiarrheal activity of cashew GUM, a complex heteropolysaccharide extracted from exudate of Anacardium occidentale L. in rodents.
    Araújo TS; Costa DS; Sousa NA; Souza LK; de Araújo S; Oliveira AP; Sousa FB; Silva DA; Barbosa AL; Leite JR; Medeiros JV
    J Ethnopharmacol; 2015 Nov; 174():299-307. PubMed ID: 26297843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
    Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
    Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscope versus microscope in the diagnosis of esophageal non-erosive reflux disease: a study of 71 cases.
    Arul P; Phansalkar M; Alexander T; Padhi S; Vinoth B
    Malays J Pathol; 2014 Dec; 36(3):181-8. PubMed ID: 25500517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.